News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
HealthCor Management, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| HealthCor Management, L.P. reports a 0% stake in Research Alliance Corp. II |
| 02/14/2022 |
SC 13G/A
| HealthCor Management, L.P. reports a 8.6% stake in Research Alliance Corp. II |
| 02/14/2022 |
SC 13G/A
| HealthCor Management, L.P. reports a 0% stake in Medicus Sciences Acquisition Corp |
| 02/14/2022 |
SC 13G/A
| HealthCor Management, L.P. reports a 0% stake in Madrigal Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| HealthCor Management, L.P. reports a 0% stake in Aurinia Pharmaceuticals Inc. |
| 02/14/2022 |
SC 13G/A
| HealthCor Management, L.P. reports a 0% stake in ARYA Sciences Acquisition Corp IV |
| 02/12/2021 |
SC 13G/A
| HealthCor Management, L.P. reports a 0% stake in Intersect ENT, Inc. |
| 02/12/2021 |
SC 13G/A
| HealthCor Management, L.P. reports a 5.8% stake in Madrigal Pharmaceuticals, Inc. |
| 02/12/2021 |
SC 13G/A
| HealthCor Management, L.P. reports a 0% stake in ViewRay, Inc. |
| 02/12/2021 |
SC 13G/A
| HealthCor Management, L.P. reports a 0.5% stake in Nevro, Corp. |
| 02/12/2021 |
SC 13G/A
| HealthCor Management, L.P. reports a 5.5% stake in Aurinia Pharmaceuticals Inc. |
| 02/12/2021 |
SC 13G/A
| HealthCor Management, L.P. reports a 0% stake in Arcturus Therapeutics Holdings Inc |
| 02/14/2020 |
SC 13G/A
| HealthCor Management, L.P. reports a 8% stake in Intersect ENT, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| HealthCor Management, L.P. reports a 7.1% stake in Madrigal Pharmaceuticals, Inc. |
| 02/14/2020 |
SC 13G/A
| HealthCor Management, L.P. reports a 0% stake in Dynavax Technologies Corp. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| HealthCor Management, L.P. reports a 8.1% stake in Intersect ENT, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| HealthCor Management, L.P. reports a 7.4% stake in Dynavax Technologies Corp. |
| 02/14/2018 |
SC 13G/A
| HealthCor Management, L.P. reports a 3.5% stake in Bioverativ, Inc. |
| 02/14/2018 |
SC 13G/A
| HealthCor Management, L.P. reports a 6.9% stake in Pacira Pharmaceuticals, Inc. |
| 02/14/2018 |
SC 13G/A
| HealthCor Management, L.P. reports a 0% stake in SeaSpine Holdings Corporation |
| 02/14/2017 |
SC 13G/A
| HealthCor Management, L.P. reports a 0% stake in Sagent Pharmaceuticals, Inc. |
| 02/14/2017 |
SC 13G/A
| HealthCor Management, L.P. reports a 0% stake in Conatus Pharmaceuticals Inc. |
| 02/14/2017 |
SC 13G/A
| HealthCor Management, L.P. reports a 1.4% stake in Clovis Oncology, Inc. |
| 02/14/2017 |
SC 13G/A
| HealthCor Management, L.P. reports a 4.5% stake in Collegium Pharmaceutical, Inc. |
| 02/14/2017 |
SC 13G/A
| SeaSpine Holdings Corp reports a 5.7% stake in SeaSpine Holdings Corporation |
| 07/24/2012 |
SC 13G/A
| HealthCor Management, L.P. reports a 1% stake in Magellan Health Services, Inc. |
| 02/13/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/13/2012 |
SC 13G/A
| HealthCor Management, L.P. reports a 7.6% stake in YM Biosciences Inc. |
| 02/13/2012 |
SC 13G/A
| HealthCor Management, L.P. reports a 4.4% stake in Salix Pharmaceuticals Ltd. |
|
|
|